Wyeth, Pfizer Push To Get Prempro MDL Tossed

Law360, New York (January 14, 2009, 12:00 AM EST) -- A group of drugmakers, including Wyeth Pharmaceuticals Inc., Bristol-Myers Squibb Co. and Pfizer Inc., struck a defiant tone Monday in a massive multidistrict litigation accusing them of advertising and selling hormone treatments that cause breast cancer, denying all allegations and asking for the case to be dismissed.

Wyeth, the first named defendant in the case, argued in the U.S. District Court for the Eastern District of Arkansas, among other things, that the manufacture, marketing and labeling of the products in question was controlled by federal law...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Prempro Products et al


Case Number

4:03-cv-01507

Court

Arkansas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Billy Roy Wilson

Date Filed

March 7, 2003

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.